Amanda Whalen, serving as the Chief Financial Officer of Klaviyo, Inc. (NYSE: KVYO), has finalized the sale of 14,000 shares of the company's Series A Common Stock. The transaction, recorded on June 18, 2026, resulted in total proceeds of $185,220. The shares were sold at varying prices throughout the day, ranging from a low of $13.12 to a high of $13.49 per share.
This divestment was executed in accordance with a Rule 10b5-1 trading plan that Ms. Whalen originally adopted on August 21, 2025. Such plans are typically utilized by corporate insiders to manage equity holdings in a compliant and systematic manner. Following the completion of this sale, Ms. Whalen's direct holdings in Klaviyo, Inc. Series A Common Stock stand at 852,192 shares. This total position comprises 73,302 vested shares, alongside 551,618 unvested restricted stock units and 227,272 unvested performance stock units. These unvested units were awarded under the company's 2023 Stock Option and Incentive Plan. The restricted stock units and performance stock units each confer the contingent right to receive one share of Series A Common Stock upon the successful vesting and settlement of the awards.
The executive transaction coincides with Klaviyo's recent financial disclosure for the first quarter of 2026. The company reported earnings per share of $0.22, surpassing the anticipated $0.20. Revenue also exceeded expectations, reaching $358 million against the projected $348.6 million. Despite these positive financial results, analyst sentiment appears cautious. Stifel adjusted its price target for Klaviyo downward from $35 to $28, citing concerns regarding guidance deceleration, though the firm maintained a Buy rating. Similarly, Piper Sandler lowered its price target from $30 to $26, expressing concerns over margins while keeping an Overweight rating. Conversely, Canaccord Genuity reiterated a Buy rating with a higher price target of $32.00, highlighting the company's growth potential within AI infrastructure.
The current market price for KVYO stands at $13.25, reflecting a decline of $0.21 or 1.56%. Following market close, the stock traded at $13.28, showing a minor gain of $0.03 or 0.23%.